{"uid":"382cf9542a37d98c","name":"TEST-SPO-116378.01","historyId":"METTA-WAM-ISSUE-116:METTA-WAM-ISSUE-116#TEST-SPO-116378.01","time":{"start":1732136910000,"stop":1732136956964,"duration":46964},"status":"passed","flaky":false,"newFailed":false,"newBroken":false,"newPassed":false,"retriesCount":0,"retriesStatusChange":false,"beforeStages":[],"testStage":{"steps":[{"name":"<![CDATA[","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"<a href=\"https://trueagi-io.github.io/metta-wam/reports/tests_output/baseline-compat/tests/baseline_compat/anti-regression/issues/metta-wam-issue-116/test_spo_116378.metta.0_failed.html#METTA-WAM-ISSUE-116.TEST-SPO-116378.01\">Test Report</a>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Assertion: (assertEqualToResult (match &hald116378 (Doxorubicin $p $o) (Doxorubicin $p $o)))","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Expected: ((Doxorubicin needed Cardiotoxicity) (Doxorubicin treat Rituximab) (Doxorubicin prolong Neoplasms) (Doxorubicin show Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin show Neoplasms) (Doxorubicin show Glioma) (Doxorubicin exhibit Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin exhibit Neoplasms) (Doxorubicin accumulate Brain_Neoplasms) (Doxorubicin monitor Neoplasms) (Doxorubicin sever Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin given Hemangiosarcoma) (Doxorubicin differ Drug-Related_Side_Effects_and_Adverse_Reactions) (Doxorubicin elevated Trastuzum...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"Actual: ((Doxorubicin stratify Liposarcoma) (Doxorubicin associated MIR375) (Doxorubicin elevated Trastuzumab) (Doxorubicin include Trastuzumab) (Doxorubicin associated Cardiotoxicity) (Doxorubicin accepted 'Lymphoma,_B-Cell') (Doxorubicin represent Breast_Neoplasms) (Doxorubicin combine Breast_Neoplasms) (Doxorubicin fit Breast_Neoplasms) (Doxorubicin lead Death) (Doxorubicin cause Cardiotoxicity) (Doxorubicin stimulate Ischemia) (Doxorubicin induce CDKN2A) (Doxorubicin affect Cardiomyopathies) (Doxorubicin evaluate CAT) (Doxorubicin evaluate GSR) (Doxorubicin evaluate Lipid_Peroxides) (Doxorubicin e...(3194)","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false},{"name":"]]>","time":{},"steps":[],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":0,"attachmentsCount":0,"hasContent":false,"attachmentStep":false}],"attachments":[],"parameters":[],"shouldDisplayMessage":false,"stepsCount":7,"attachmentsCount":0,"hasContent":true,"attachmentStep":false},"afterStages":[],"labels":[{"name":"resultFormat","value":"junit"},{"name":"suite","value":"METTA-WAM-ISSUE-116"},{"name":"testClass","value":"METTA-WAM-ISSUE-116"},{"name":"package","value":"METTA-WAM-ISSUE-116"}],"parameters":[],"links":[],"hidden":false,"retry":false,"extra":{"severity":"normal","retries":[],"categories":[],"history":{"statistic":{"failed":0,"broken":0,"skipped":0,"passed":49,"unknown":0,"total":49},"items":[{"uid":"1976caca15934c5e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/518//#testresult/1976caca15934c5e","status":"passed","time":{"start":1732109033000,"stop":1732109079646,"duration":46646}},{"uid":"4dc0a40f7e4e71ce","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/517//#testresult/4dc0a40f7e4e71ce","status":"passed","time":{"start":1732105848000,"stop":1732105895516,"duration":47516}},{"uid":"df65851adf3a9480","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/516//#testresult/df65851adf3a9480","status":"passed","time":{"start":1732104957000,"stop":1732105003452,"duration":46452}},{"uid":"b83f6d11d42e50ca","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/515//#testresult/b83f6d11d42e50ca","status":"passed","time":{"start":1732104581000,"stop":1732104627883,"duration":46883}},{"uid":"7a3bf7468ca45122","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/514//#testresult/7a3bf7468ca45122","status":"passed","time":{"start":1732103802000,"stop":1732103849237,"duration":47237}},{"uid":"24be38d15c964d0d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/512//#testresult/24be38d15c964d0d","status":"passed","time":{"start":1732042383000,"stop":1732042429187,"duration":46187}},{"uid":"3300a5d99328a183","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/510//#testresult/3300a5d99328a183","status":"passed","time":{"start":1731993967000,"stop":1731994013431,"duration":46431}},{"uid":"fe6e4200eca793d7","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/511//#testresult/fe6e4200eca793d7","status":"passed","time":{"start":1731993981000,"stop":1731994028259,"duration":47259}},{"uid":"f934173e36619b7b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/509//#testresult/f934173e36619b7b","status":"passed","time":{"start":1731993859000,"stop":1731993907036,"duration":48036}},{"uid":"3f557be5c21a6cc7","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/507//#testresult/3f557be5c21a6cc7","status":"passed","time":{"start":1731971454000,"stop":1731971500888,"duration":46888}},{"uid":"2e2b174ff170737a","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/503//#testresult/2e2b174ff170737a","status":"passed","time":{"start":1731711806000,"stop":1731711854376,"duration":48376}},{"uid":"54851f41cd89fb3c","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/502//#testresult/54851f41cd89fb3c","status":"passed","time":{"start":1731707812000,"stop":1731707860537,"duration":48537}},{"uid":"a80fe97a1ef3b394","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/501//#testresult/a80fe97a1ef3b394","status":"passed","time":{"start":1731707116000,"stop":1731707163891,"duration":47891}},{"uid":"48aa48a5297a0d3d","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/498//#testresult/48aa48a5297a0d3d","status":"passed","time":{"start":1731616405000,"stop":1731616452648,"duration":47648}},{"uid":"3689ae44a96833a0","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/499//#testresult/3689ae44a96833a0","status":"passed","time":{"start":1731616461000,"stop":1731616509340,"duration":48340}},{"uid":"8012458edf52c76e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/497//#testresult/8012458edf52c76e","status":"passed","time":{"start":1731608327000,"stop":1731608375068,"duration":48068}},{"uid":"e7257efd077b869e","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/496//#testresult/e7257efd077b869e","status":"passed","time":{"start":1731549965000,"stop":1731550013410,"duration":48410}},{"uid":"da3a6319fc1b796b","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/494//#testresult/da3a6319fc1b796b","status":"passed","time":{"start":1731538621000,"stop":1731538669054,"duration":48054}},{"uid":"755ac01fd1a2b6e5","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/493//#testresult/755ac01fd1a2b6e5","status":"passed","time":{"start":1731538469000,"stop":1731538516463,"duration":47463}},{"uid":"6f30d3d4515425f4","reportUrl":"https://trueagi-io.github.io/metta-wam/ci/492//#testresult/6f30d3d4515425f4","status":"passed","time":{"start":1731472385000,"stop":1731472433234,"duration":48234}}]},"tags":[]},"source":"382cf9542a37d98c.json","parameterValues":[]}